Advanced search
Publication Cover
Annals of Medicine Volume 40, 2008 - Issue 6
Submit an article Journal homepage
1,391
Views
89
CrossRef citations to date
0
Altmetric
Review Article

Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation

Andrea Rubboli Division of Cardiology, Cardiac Catheterization Laboratory, Maggiore Hospital, Bologna, Italy
, FESC , MD,
Jonathan L. Halperin The Cardiovascular Institute, Mount Sinai Medical Center, New York, New York, USA
,
K. E. Juhani Airaksinen Department of Medicine, University of Turku, Finland
,
Michael Buerke Department of Medicine III, Martin Luther-University, Halle-Wittenberg, Germany
,
Eric Eeckhout Division of Cardiology, Centre Hospitalier Universitaire Vaudoise, Lausanne, Switzerland
,
Saul B. Freedman Department of Cardiology, Concord Hospital and Anzac Research Institute, University of Sydney, Australia
,
Anthony H. Gershlick Department of Cardiology, University Hospitals of Leicester, Leicester, UK
,
Axel Schlitt Department of Medicine III, Martin Luther-University, Halle-Wittenberg, Germany
,
Hung Fat Tse Cardiology Division, Department of Medicine, University of Hong Kong, Hong Kong, China
,
Freek W. A. Verheugt Department of Cardiology, University Medical Center, Nijmegen, The Netherlands
&
Gregory Y. H. Lip University Department of Medicine, City Hospital, Birmingham, UK
 show all
Pages 428-436 | Published online: 08 Jul 2009

Citations (89)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Byron Cryer & Kenneth W Mahaffey. (2014) Gastrointestinal ulcers, role of aspirin, and clinical outcomes: pathobiology, diagnosis, and treatment. Journal of Multidisciplinary Healthcare 7, pages 137-146.
Read now
Vijay A Doraiswamy, Marvin J Slepian, Martin G Gesheff, Udaya S Tantry & Paul A Gurbel. (2013) Potential role of oral anticoagulants in the treatment of patients with coronary artery disease: focus on dabigatran. Expert Review of Cardiovascular Therapy 11:9, pages 1259-1267.
Read now
Antti-Pekka Annala, Pasi P. Karjalainen, Fausto Biancari, Matti Niemelä, Antti Ylitalo, Saila Vikman, Pekka Porela & K. E. Juhani Airaksinen. (2012) Long-term safety of drug-eluting stents in patients on warfarin treatment. Annals of Medicine 44:3, pages 271-278.
Read now
Lars Maegdefessel, Junya Azuma & Philip S Tsao. (2010) Modern role for clopidogrel in management of atrial fibrillation and stroke reduction. Vascular Health and Risk Management 6, pages 95-103.
Read now
Dennis H Lau, Muayad Alasady, Anthony G Brooks & Prashanthan Sanders. (2010) New-onset atrial fibrillation and acute coronary syndrome. Expert Review of Cardiovascular Therapy 8:7, pages 941-948.
Read now

Articles from other publishers (84)

Ko Yamamoto, Hiroki Shiomi, Takeshi Morimoto, Masahiro Natsuaki, Yasuaki Takeji, Hirotoshi Watanabe, Yusuke Yoshikawa, Yukiko Matsumura-Nakano, Satoshi Shizuta, Kengo Tanabe, Kenji Ando, Kazushige Kadota, Yoshihiro Morino, Ken Kozuma, Yoshihisa Nakagawa & Takeshi Kimura. (2020) Effect of Renal Dysfunction on the Risks for Ischemic and Bleeding Events in Patients With Atrial Fibrillation Receiving Percutaneous Coronary Intervention. The American Journal of Cardiology 125:3, pages 399-408.
Crossref
Andrea Rubboli. (2019) And now we have the AUGUSTUS … How will it impact on antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention?. European Journal of Internal Medicine 65, pages 1-3.
Crossref
Prasad S. Nishtala, Hamish A. Jamieson, H. Carl Hanger, Te-yuan Chyou & Sarah N. Hilmer. (2019) Examining the Risks of Major Bleeding Events in Older People Using Antithrombotics. Cardiovascular Drugs and Therapy 33:3, pages 323-329.
Crossref
Juan M. Ruiz-Nodar, Fernando Torres Mezcúa & Cristina Cambra Poveda. (2019) Intervención coronaria percutánea y anticoagulantes orales. Revista Española de Cardiología Suplementos 18, pages 21-26.
Crossref
Andrei I. Komarov. (2018) CLINICAL IMPRESSION: PLANNED PERCUTANEOUS CORONARY INTERVENTION IN A PATIENT WITH ATRIAL FIBRILLATION. Atherothrombosis Journal:2, pages 92-102.
Crossref
Isabel Wustrow, Nikolaus Sarafoff, Bernhard Haller, Lisa Rössner, Dirk Sibbing, Stefanie Schüpke, Tareq Ibrahim, Aida Anetsberger, Heribert Schunkert, Karl‐Ludwig Laugwitz, Adnan Kastrati & Isabell Bernlochner. (2018) Real clinical experiences of dual versus triple antithrombotic therapy after percutaneous coronary intervention. Catheterization and Cardiovascular Interventions 92:7, pages 1239-1246.
Crossref
Heli M. Lahtela, Aissa Bah, Tuomas Kiviniemi, Wail Nammas, Axel Schlitt, Andrea Rubboli, Pasi P. Karjalainen, Marco Proietti, Juha E.K. Hartikainen, Gregory Y.H. Lip & K.E. Juhani Airaksinen. (2017) Outcome of octogenarians with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry. Clinical Cardiology 40:12, pages 1264-1270.
Crossref
Antoni Bayés de Luna & Adrian Baranchuk. 2017. Clinical Arrhythmology. Clinical Arrhythmology 83 163 .
Takashi Miura, Yusuke Miyashita, Hirohiko Motoki, Hideki Kobayashi, Masanori Kobayashi, Hiroyuki Nakajima, Hikaru Kimura, Hiroshi Akanuma, Eiichiro Mawatari, Toshio Sato, Shoji Hotta, Yuichi Kamiyoshi, Takuya Maruyama, Noboru Watanabe, Takayuki Eizawa, Shinichi Aso, Shinichiro Uchikawa, Naoto Hashizume, Keisuke Senda, Takehiro Morita, Soichiro Ebisawa, Atsushi Izawa, Jun Koyama & Uichi Ikeda. (2016) Comparison of mid-term outcomes between patients with and without atrial fibrillation undergoing coronary stenting in the second-generation drug-eluting stent era: from the SHINANO registry. Cardiovascular Intervention and Therapeutics 32:3, pages 206-215.
Crossref
Chao-Feng Chen, Bin Chen, Jue Zhu & Yi-Zhou Xu. (2015) Antithrombotic therapy after percutaneous coronary intervention in patients requiring oral anticoagulant treatment. Herz 40:8, pages 1070-1083.
Crossref
Imdad Ahmed & Stephen J. Voyce. (2015) Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction in a Patient Taking Dabigatran for Chronic Anticoagulation. Texas Heart Institute Journal 42:2, pages 158-161.
Crossref
James F. Meschia, Cheryl Bushnell, Bernadette Boden-Albala, Lynne T. Braun, Dawn M. Bravata, Seemant Chaturvedi, Mark A. Creager, Robert H. Eckel, Mitchell S.V. Elkind, Myriam Fornage, Larry B. Goldstein, Steven M. Greenberg, Susanna E. Horvath, Costantino Iadecola, Edward C. Jauch, Wesley S. Moore & John A. Wilson. (2014) Guidelines for the Primary Prevention of Stroke. Stroke 45:12, pages 3754-3832.
Crossref
N. Bennaghmouch, W. J. M. Dewilde & J. M. Ten Berg. (2014) Dual Antiplatelet Therapy in the Anticoagulated Patient Undergoing Percutaneous Coronary Intervention Risks, Benefits, and Unanswered Questions. Current Cardiology Reports 16:12.
Crossref
Stavros Konstantinides & Adam Torbicki. (2014) Management of venous thrombo-embolism: an update. European Heart Journal 35:41, pages 2855-2863.
Crossref
A. Rubboli, D. P. Faxon, K. E. Juhani Airaksinen, A. Schlitt, F. Mar?n, D. L. Bhatt & G. Y. H. Lip. (2014) The optimal management of patients on oral anticoagulation undergoing coronary artery stenting. Thrombosis and Haemostasis 112:6, pages 1080-1087.
Crossref
Willem J.M. Dewilde, Paul W.A. Janssen, Freek W.A. Verheugt, Robert F. Storey, Tom Adriaenssens, Morten L. Hansen, Morten Lamberts & Jurri?n M. ten Berg. (2014) Triple Therapy for Atrial Fibrillation and Percutaneous Coronary Intervention. Journal of the American College of Cardiology 64:12, pages 1270-1280.
Crossref
Marja Puurunen, Tuomas Kiviniemi, Wail Nammas, Axel Schlitt, Andrea Rubboli, Kai Nyman, Pasi Karjalainen, Paulus Kirchhof, Gregory Y H Lip & Juhani K E Airaksinen. (2014) Impact of anaemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry. BMJ Open 4:5, pages e004700.
Crossref
W. Schuyler Jones, Xiaojuan Mi, Manesh R. Patel, Roger Mills, Adrian F. Hernandez & Lesley H. Curtis. (2014) Combined Use of Warfarin and Oral P2Y12 Inhibitors in Patients With Atrial Fibrillation and Acute Coronary Syndrome. Clinical Cardiology 37:3, pages 152-159.
Crossref
N. Bennaghmouch, D. Sprenkeler, K. Qaderdan & J. M. ten Berg. (2014) Optimizing Antithrombotic Therapy After Coronary Stent Implantation in Patients on Chronic Oral Anticoagulation. Journal of Cardiovascular Translational Research 7:1, pages 64-71.
Crossref
M. Moser, C. B. Olivier & C. Bode. (2013) Triple antithrombotic therapy in cardiac patients: more questions than answers. European Heart Journal 35:4, pages 216-223.
Crossref
Tuomas Kiviniemi, Marja Puurunen, Axel Schlitt, Andrea Rubboli, Pasi Karjalainen, Wail Nammas, Paulus Kirchhof, Fausto Biancari, Gregory YH Lip & KE Juhani Airaksinen. (2014) Bare-Metal vs. Drug-Eluting Stents in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. Circulation Journal 78:11, pages 2674-2681.
Crossref
Emil L. Fosbol, Tracy Y. Wang, Shuang Li, Jonathan Piccini, Renato D. Lopes, Roger M. Mills, Winslow Klaskala, Laine Thomas, Matthew T. Roe & Eric D. Peterson. (2013) Warfarin use among older atrial fibrillation patients with non?ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy. American Heart Journal 166:5, pages 864-870.
Crossref
Morten Lamberts, Gunnar H. Gislason, Jonas Bjerring Olesen, Søren Lund Kristensen, Anne-Marie Schjerning Olsen, Anders Mikkelsen, Christine Benn Christensen, Gregory Y.H. Lip, Lars Køber, Christian Torp-Pedersen & Morten Lock Hansen. (2013) Oral Anticoagulation and Antiplatelets in Atrial Fibrillation Patients After Myocardial Infarction and Coronary Intervention. Journal of the American College of Cardiology 62:11, pages 981-989.
Crossref
Edgar Argulian. (2013) Atrial Fibrillation and Acute Myocardial Infarction: Antithrombotic Therapy and Outcomes. The American Journal of Medicine 126:5, pages e19.
Crossref
G.Y.H. Lip. (2013) Recommendations for thromboprophylaxis in the 2012 focused update of the ESC guidelines on atrial fibrillation: a commentary. Journal of Thrombosis and Haemostasis 11:4, pages 615-626.
Crossref
G. Denas, S. Padayattil Jose, P. Gresele, N. Erba, S. Testa, V. De Micheli, R. Quintavalla, D. Poli, A. Bracco, T. Fierro, S. Iliceto & V. Pengo. (2012) Major bleeding in patients undergoing PCI and triple or dual antithrombotic therapy: a parallel-cohort study. Journal of Thrombosis and Thrombolysis 35:2, pages 178-184.
Crossref
Anne Bernard, Laurent Fauchier, Céline Pellegrin, Nicolas Clementy, Christophe Saint Etienne, Amitava Banerjee, Djedjiga Naudin & Denis Angoulvant. (2017) Anticoagulation in patients with atrial fibrillation undergoing coronary stent implantation. Thrombosis and Haemostasis 110:09, pages 560-568.
Crossref
Gabriel Steg, Stefan K. James, Dan Atar, Luigi P. Badano, Carina Blomstrom Lundqvist, Michael A. Borger, Carlo di Mario, Kenneth Dickstein, Gregory Ducrocq, Francisco Fernández-Avilés, Anthony H. Gershlick, Pantaleo Giannuzzi, Sigrun Halvorsen, Kurt Huber, Peter Juni, Adnan Kastrati, Juhani Knuuti, Mattie J. Lenzen, Kenneth W. Mahaffey, Marco Valgimigli, Arnoud van’t Hof, Petr Widimsky, Doron Zahger, Jeroen J. Bax, Helmut Baumgartner, Claudio Ceconi, Veronica Dean, Christi Deaton, Robert Fagard, Christian Funck-Brentano, David Hasdai, Arno Hoes, Paulus Kirchhof, Juhani Knuuti, Philippe Kolh, Theresa McDonagh, Cyril Moulin, Bogdan A. Popescu, Zeljko Reiner, Udo Sechtem, Per Anton Sirnes, Michal Tendera, Adam Torbicki, Alec Vahanian, Stephan Windecker, Felicity Astin, Karin Astrom-Olsson, Andrzej Budaj, Peter Clemmensen, Jean-Philippe Collet, Keith A. Fox, Ahmet Fuat, Olivija Gustiene, Christian W. Hamm, Petr Kala, Patrizio Lancellotti, Aldo Pietro Maggioni, Béla Merkely, Franz-Josef Neumann, Massimo F. Piepoli, Frans van de Werf, Freek Verheugt & Lars Wallentin. (2013) Guía de práctica clínica de la ESC para el manejo del infarto agudo de miocardio en pacientes con elevación del segmento ST. Revista Española de Cardiología 66:1, pages 53.e1-53.e46.
Crossref
Katherine Patton. 2013. Handbook of Clinical Nutrition and Stroke. Handbook of Clinical Nutrition and Stroke 81 94 .
Melina Gattellari, John M Worthington, Dominic Y Leung & Nicholas Zwar. (2012) Supporting Treatment decision making to Optimise the Prevention of STROKE in Atrial Fibrillation: The STOP STROKE in AF study. Protocol for a cluster randomised controlled trial. Implementation Science 7:1.
Crossref
Ron Pisters & Harry J CrijnsAndrea Rubboli. 2012. Stroke Prevention in Atrial Fibrillation. Stroke Prevention in Atrial Fibrillation 82 98 .
Ph. Gabriel Steg, Stefan K. James, Dan Atar, Luigi P. Badano, Carina Blomstrom Lundqvist, Michael A. Borger, Carlo Di Mario, Kenneth Dickstein, Gregory Ducrocq, Francisco Fernandez-Aviles, Anthony H. Gershlick, Pantaleo Giannuzzi, Sigrun Halvorsen, Kurt Huber, Peter Juni, Adnan Kastrati, Juhani Knuuti, Mattie J. Lenzen, Kenneth W. Mahaffey, Marco Valgimigli, Arnoud van't Hof, Petr Widimsky, Doron Zahger, Jeroen J. Bax, Helmut Baumgartner, Claudio Ceconi, Veronica Dean, Christi Deaton, Robert Fagard, Christian Funck-Brentano, David Hasdai, Arno Hoes, Paulus Kirchhof, Juhani Knuuti, Philippe Kolh, Theresa McDonagh, Cyril Moulin, Bogdan A. Popescu, Željko Reiner, Udo Sechtem, Per Anton Sirnes, Michal Tendera, Adam Torbicki, Alec Vahanian, Stephan Windecker, David Hasdai, Felicity Astin, Karin Åström-Olsson, Andrzej Budaj, Peter Clemmensen, Jean-Philippe Collet, Keith A. Fox, Ahmet Fuat, Olivija Gustiene, Christian W. Hamm, Petr Kala, Patrizio Lancellotti, Aldo Pietro Maggioni, Béla Merkely, Franz-Josef Neumann, Massimo F. Piepoli, Frans Van de Werf, Freek Verheugt & Lars Wallentin. (2012) ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal 33:20, pages 2569-2619.
Crossref
Aldo Pietro Maggioni. (2012) Acute Coronary Syndrome in Patients With Atrial Fibrillation. Circulation 126:10, pages 1176-1178.
Crossref
Morten LambertsJonas Bjerring OlesenMartin Huth RuwaldCarolina Malta HansenDeniz KarasoySøren Lund KristensenLars KøberChristian Torp-PedersenGunnar Hilmar GislasonMorten Lock Hansen. (2012) Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention. Circulation 126:10, pages 1185-1193.
Crossref
Arden R. Barry & Margaret L. Ackman. (2012) Triple antithrombotic therapy in patients with atrial fibrillation who have undergone percutaneous coronary intervention with stent implantation. American Journal of Health-System Pharmacy 69:17, pages 1485-1493.
Crossref
Andrea Rubboli. (2011) The antithrombotic management of patients on oral anticoagulation undergoing coronary stent implantation: an update. Internal and Emergency Medicine 7:4, pages 299-304.
Crossref
Andrea Rubboli, Paolo Magnavacchi, Paolo Guastaroba, Francesco Saia, Luigi Vignali, Paola Giacometti, Nicoletta Franco, Alberto Benassi, Elisabetta Varani, Gianluca Campo, Antonio Manari, Rossana De Palma & Antonio Marzocchi. (2012) Antithrombotic Management and 1-Year Outcome of Patients on Oral Anticoagulation Undergoing Coronary Stent Implantation (from the Registro Regionale Angioplastiche Emilia-Romagna Registry). The American Journal of Cardiology 109:10, pages 1411-1417.
Crossref
ANDREA RUBBOLI, WILLEM DEWILDE, KURT HUBER, ERIC EECKHOUT, ISTVÀN HERZFELD, JOSÈ VALENCIA, STEPHAN WINDECKER, K. E. JUHANI AIRAKSINEN & GREGORY Y. H. LIP. (2011) The Management of Patients on Oral Anticoagulation Undergoing Coronary Stent Implantation: A Survey among Interventional Cardiologists from Eight European Countries. Journal of Interventional Cardiology 25:2, pages 163-169.
Crossref
Emil L. Fosbol, Tracy Y. Wang, Shuang Li, Jonathan P. Piccini, Renato D. Lopes, Bimal Shah, Roger M. Mills, Winslow Klaskala, Karen P. Alexander, Laine Thomas, Matthew T. Roe & Eric D. Peterson. (2012) Safety and effectiveness of antithrombotic strategies in older adult patients with atrial fibrillation and non?ST elevation myocardial infarction. American Heart Journal 163:4, pages 720-728.
Crossref
Walter Ageno, Alexander S. Gallus, Ann Wittkowsky, Mark Crowther, Elaine M. Hylek & Gualtiero Palareti. (2012) Oral Anticoagulant Therapy. Chest 141:2, pages e44S-e88S.
Crossref
William Chan, Andrew E. Ajani, David J. Clark, Dion Stub, Nick Andrianopoulos, Angela L. Brennan, Gishel New, Martin Sebastian, Rozanne Johnston, Antony Walton, Christopher M. Reid, Anthony M. Dart & Stephen J. Duffy. (2012) Impact of Periprocedural Atrial Fibrillation on Short-Term Clinical Outcomes Following Percutaneous Coronary Intervention. The American Journal of Cardiology 109:4, pages 471-477.
Crossref
Rubboli Andrea. (2012) The risk of bleeding of triple therapy with vitamin K-antagonists, aspirin and clopidogrel after coronary stent implantation: Facts and questions. Journal of Geriatric Cardiology 8:4, pages 207-214.
Crossref
Jonas Bjerring Olesen, Gunnar Hilmar Gislason, Christian Torp-Pedersen & Gregory Y. H. Lip. (2012) Atrial Fibrillation and Vascular Disease-A Bad Combination. Clinical Cardiology 35:S1, pages S15-S20.
Crossref
Melina Gattellari, Dominic Y Leung, Obioha C Ukoumunne, Nicholas Zwar, Jeremy Grimshaw & John M Worthington. (2011) Study protocol: the DESPATCH study: Delivering stroke prevention for patients with atrial fibrillation - a cluster randomised controlled trial in primary healthcare. Implementation Science 6:1.
Crossref
Álvaro Merino, Inmaculada Roldán, Francisco Marín & Fernando Worner. (2011) Prevención de complicaciones hemorrágicas en el síndrome coronario agudo. Medicina Clínica 137:14, pages 650-655.
Crossref
John Fani Srour & Gerald W. Smetana. (2011) Triple therapy in hospitalized patients: Facts and controversies. Journal of Hospital Medicine 6:9, pages 537-545.
Crossref
D. Sander, H. Poppert, K. Sander & T. Etgen. (2011) Primärprävention des Schlaganfalls – Was ist neu?. Aktuelle Neurologie 38:08, pages 414-427.
Crossref
Juan M. Ruiz-Nodar, Francisco Marín, Sergio Manzano-Fernández, José Valencia-Martín, José A. Hurtado, Vanessa Roldán, Javier Pineda, Eduardo Pinar, Francisco Sogorb, Mariano Valdés & Gregory Y.H. Lip. (2011) An Evaluation of the CHADS2 Stroke Risk Score in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Revascularization. Chest 139:6, pages 1402-1409.
Crossref
Andrea Rubboli, Jason C. Kovacic, Roxana Mehran & Gregory Y.H. Lip. (2011) Coronary Stent Implantation in Patients Committed to Long-term Oral Anticoagulation Therapy. Chest 139:5, pages 981-987.
Crossref
Antoni Bayés de Luna. 2011. Clinical Arrhythmology. Clinical Arrhythmology 93 180 .
John O. MasonIIIIII, Shelly R. Gupta, Christopher J. Compton, Paul A. Frederick, Michael G. Neimkin, Mark L. Hill, Mila J. Heersink, Rachel S. Vail, Milton F. WhiteJrJr, Richard M. Feist, Martin L. Thomley & Michael A. AlbertJrJr. (2011) Comparison of Hemorrhagic Complications of Warfarin and Clopidogrel Bisulfate in 25-Gauge Vitrectomy versus a Control Group. Ophthalmology 118:3, pages 543-547.
Crossref
Hong-Jin Zhao, Zhao-Tong Zheng, Zhi-Hao Wang, Shao-Hua Li, Yun Zhang, Ming Zhong & Wei Zhang. (2011) ?Triple Therapy? Rather Than ?Triple Threat?. Chest 139:2, pages 260-270.
Crossref
Angie Ghattas, Eduard Shantsila & Gregory Y. H. Lip. (2011) Antithrombotic therapy after percutaneous coronary intervention in anticoagulated patients: a fine balance between thrombosis and bleeding. Therapeutic Advances in Cardiovascular Disease 5:1, pages 5-9.
Crossref
Marc FisherJoseph Loscalzo. (2011) The Perils of Combination Antithrombotic Therapy and Potential Resolutions. Stroke 42:2, pages 278-281.
Crossref
Larry B. Goldstein, Cheryl D. Bushnell, Robert J. Adams, Lawrence J. Appel, Lynne T. Braun, Seemant Chaturvedi, Mark A. Creager, Antonio Culebras, Robert H. Eckel, Robert G. Hart, Judith A. Hinchey, Virginia J. Howard, Edward C. Jauch, Steven R. Levine, James F. Meschia, Wesley S. Moore, J.V. (Ian) Nixon & Thomas A. Pearson. (2011) Guidelines for the Primary Prevention of Stroke. Stroke 42:2, pages 517-584.
Crossref
Michael Broukhim & Jonathan L. Halperin. (2010) Stroke Prevention in the High-risk Atrial Fibrillation Patient: Medical Management. Current Cardiology Reports 13:1, pages 9-17.
Crossref
Marc FisherJoseph Loscalzo. (2011) The Perils of Combination Antithrombotic Therapy and Potential Resolutions. Circulation 123:3, pages 232-235.
Crossref
Selvakumar Velu & Gregory YH Lip. (2011) Recent Progress in Antithrombotic Therapy for Atrial Fibrillation. Journal of Atherosclerosis and Thrombosis 18:4, pages 257-273.
Crossref
Caroline MediGraeme J. HankeySaul B. Freedman. (2010) Stroke Risk and Antithrombotic Strategies in Atrial Fibrillation. Stroke 41:11, pages 2705-2713.
Crossref
Erin Jamula, Nancy S. Lloyd, Jon-David Schwalm, K.E. Juhani Airaksinen & James D. Douketis. (2010) Safety of Uninterrupted Anticoagulation in Patients Requiring Elective Coronary Angiography With or Without Percutaneous Coronary Intervention. Chest 138:4, pages 840-847.
Crossref
K.E. Airaksinen, Axel Schlitt, Andrea Rubboli, Pasi Karjalainen & Gregory Lip. (2010) How to manage antithrombotic treatment during percutaneous coronary interventions in patients receiving long-term oral anticoagulation: to "bridge" or not to "bridge"?. EuroIntervention 6:4, pages 520-526.
Crossref
W. Dewilde, N. Breet, J. J. Koolen & J. M. Ten Berg. (2010) ‘Ins’ and ‘outs’ of triple therapy. Netherlands Heart Journal 18:9, pages 444-450.
Crossref
K.E. Juhani Airaksinen, Hanna Suurmunne, Pekka Porela, Matti Niemelä, Saila Vikman, Marja Puurunen, Antti-Pekka Annala, Fausto Biancari & Pasi P. Karjalainen. (2010) Usefulness of Outpatient Bleeding Risk Index to Predict Bleeding Complications in Patients With Long-term Oral Anticoagulation Undergoing Coronary Stenting. The American Journal of Cardiology 106:2, pages 175-179.
Crossref
G. Y. H. Lip, K. Huber, F. Andreotti, H. Arnesen, J. K. Airaksinen, T. Cuisset, P. Kirchhof & F. Marin. (2010) Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). European Heart Journal 31:11, pages 1311-1318.
Crossref
Vincenzo Pasceri, Giuseppe Patti, Christian Pristipino, Francesco Pelliccia, Diego Irini, Antonio Varveri, Adriana Roncella, Germano Di Sciascio & Giulio Speciale. (2010) Safety of drug eluting stents in patients on chronic anticoagulation using long‐term single antiplatelet treatment with clopidogrel. Catheterization and Cardiovascular Interventions 75:6, pages 936-942.
Crossref
KE Juhani Airaksinen, Antti Ylitalo & Pasi P Karjalainen. (2010) Drug-eluting stents in patients on long-term oral anticoagulation therapy: a mission impossible?. Interventional Cardiology 2:2, pages 127-135.
Crossref
Dennis T. KoLingsong YunHarindra C. WijeysunderaCynthia A. JackeviciusSunil V. RaoPeter C. AustinJean-François MarquisJack V. Tu. (2010) Incidence, Predictors, and Prognostic Implications of Hospitalization for Late Bleeding After Percutaneous Coronary Intervention for Patients Older Than 65 Years. Circulation: Cardiovascular Interventions 3:2, pages 140-147.
Crossref
S. SCHULMAN & F.A. SPENCER. (2010) Antithrombotic drugs in coronary artery disease: risk benefit ratio and bleeding. Journal of Thrombosis and Haemostasis 8:4, pages 641-650.
Crossref
Willem Dewilde, Nicolien Breet & Jurrien Ten Berg. (2010) Triple Therapy: Triple Safety or Triple Danger?. The American Journal of Cardiology 105:4, pages 579.
Crossref
Andrea Rubboli. (2010) Antithrombotic management of patients on oral anticoagulation undergoing coronary artery stenting. World Journal of Cardiology 2:3, pages 64.
Crossref
Willem Dewilde, Nicolien Breet & Jurri?n Ten Berg. (2010) Triple therapy: the future or from the past?. EuroIntervention 5:6, pages 650-650.
Crossref
Andrea Rubboli, Axel Schlitt, Juhani Airaksinen & Gregory Lip. (2010) Bleeding after coronary stenting in patients on oral anticoagulation: who is guilty?. EuroIntervention 5:6, pages 649-650.
Crossref
Paulus Kirchhof, Jeroen Bax, Carina Blomstrom-Lundquist, Hugh Calkins, A. John Camm, Ricardo Cappato, Francisco Cosio, Harry Crijns, Hans-Christian Diener, Andreas Goette, Carsten W. Israel, Karl-Heinz Kuck, Gregory Y.H. Lip, Stanley Nattel, Richard L. Page, Ursula Ravens, Ulrich Schotten, Gerhard Steinbeck, Panos Vardas, Albert Waldo, Karl Wegscheider, Stephan Willems & G?nter Breithardt. (2009) Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference ?research perspectives in AF?. European Heart Journal 30:24, pages 2969-2980.
Crossref
Issam D. Moussa & Antonio Colombo. (2009) Antiplatelet therapy discontinuation following drug‐eluting stent placement: Dangers, reasons, and management recommendations. Catheterization and Cardiovascular Interventions 74:7, pages 1047-1054.
Crossref
Willem Dewilde & Jurri?n Ten Berg. (2009) Design and rationale of the WOEST trial: What is the Optimal antiplatElet and anticoagulant therapy in patients with oral anticoagulation and coronary StenTing (WOEST). American Heart Journal 158:5, pages 713-718.
Crossref
Gregory Y.H. Lip & Deirdre A. Lane. (2009) Combination Anticoagulant and Antiplatelet Therapy in Atrial Fibrillation Patients. Revista Espa?ola de Cardiolog?a (English Edition) 62:9, pages 972-974.
Crossref
Gregory Y.H. Lip & Deirdre A. Lane. (2009) Tratamiento anticoagulante y antiagregante plaquetario combinado en pacientes con fibrilación auricular. Revista Española de Cardiología 62:9, pages 972-975.
Crossref
R. D. Lopes, L. E. Elliott, H. D. White, J. S. Hochman, F. Van de Werf, D. Ardissino, T. T. Nielsen, W. D. Weaver, P. Widimsky, P. W. Armstrong & C. B. Granger. (2009) Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial. European Heart Journal 30:16, pages 2019-2028.
Crossref
ANDREA RUBBOLI, MAURO COLLETTA, JOSÈ VALENCIA, ALESSANDRO CAPECCHI, NICOLETTA FRANCO, LUISA ZANOLLA, LUIGI LA VECCHIA, GIANCARLO PIOVACCARI & GIUSEPPE DI PASQUALE. (2009) Periprocedural Management and In-Hospital Outcome of Patients with Indication for Oral Anticoagulation Undergoing Coronary Artery Stenting. Journal of Interventional Cardiology 22:4, pages 390-397.
Crossref
F. Marin, P. Kirchhof & G. Y.H. Lip. (2009) Antithrombotic therapy use for patients with atrial fibrillation undergoing percutaneous coronary intervention: new data in an area of limited evidence. Europace 11:7, pages 842-843.
Crossref
P. Halbfass, S. Janko, U. Dorwarth, G. Riess, D. Antoni & E. Hoffmann. (2009) Dilemma of antithrombotic therapy in anticoagulated atrial fibrillation patients squeezed between thrombosis and bleeding events: a single-centre experience. Europace 11:7, pages 957-960.
Crossref
P. Kirchhof, J. Bax, C. Blomstrom-Lundquist, H. Calkins, A. J. Camm, R. Cappato, F. Cosio, H. Crijns, H.-C. Diener, A. Goette, C. W. Israel, K.-H. Kuck, G. Y.H. Lip, S. Nattel, R. L. Page, U. Ravens, U. Schotten, G. Steinbeck, P. Vardas, A. Waldo, K. Wegscheider, S. Willems & G. Breithardt. (2009) Early and comprehensive management of atrial fibrillation: Proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'. Europace 11:7, pages 860-885.
Crossref
Andrea Rubboli, Leonardo Bolognese, Giuseppe Di Pasquale, Marcello Galvani, Luigi La Vecchia & Aldo P Maggioni. (2009) A prospective multicentre observational study on the management of patients on oral anticoagulation undergoing coronary artery stenting: rationale and design of the ongoing warfarin and coronary stenting (WAR-STENT) registry. Journal of Cardiovascular Medicine 10:2, pages 200-203.
Crossref
J. M. Ruiz-Nodar, F. Marin, J. Sanchez-Paya, J. A. Hurtado, J. Valencia-Martin, S. Manzano-Fernandez, V. Roldan, V. Perez-Andreu, F. Sogorb, M. Valdes & G. Y.H. Lip. (2008) Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation. European Heart Journal 30:8, pages 932-939.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.